Mucha R F
Biobehavioral Research Department, Addiction Research Foundation, Toronto, Ont., Canada.
Brain Res. 1987 Aug 25;418(2):214-20. doi: 10.1016/0006-8993(87)90088-6.
Rats implanted for 5 days with a morphine pellet were dosed once with naltrexone (subcutaneous, s.c.) or methylnaltrexone (intraventricular, i.c.v.). Then the rats were observed for several somatic signs of precipitated withdrawal and tested for aversion to the place of the withdrawal. The two antagonist treatments produced different withdrawal syndromes, but both were associated with a place aversion which followed a simple monophasic function of the dose of antagonist. More importantly, there was an absence of any overall relation between individual withdrawal signs (jumping, writhing, shaking, diarrhea, and weight loss) and the aversive effect seen. It was concluded, therefore, that the motivational impact of opiate abstinence is not always addressed in conventional models of withdrawal.
给植入吗啡丸5天的大鼠皮下注射一次纳曲酮或脑室内注射一次甲基纳曲酮。然后观察大鼠出现的几种戒断躯体症状,并测试其对戒断场所的厌恶程度。两种拮抗剂治疗产生了不同的戒断综合征,但两者都与场所厌恶有关,场所厌恶随拮抗剂剂量呈简单的单相函数变化。更重要的是,个体戒断症状(跳跃、扭体、颤抖、腹泻和体重减轻)与所观察到的厌恶效应之间不存在任何总体关联。因此得出结论,在传统的戒断模型中,阿片类药物戒断的动机影响并未总是得到体现。